biotech / news / / MarketScreener
Amgen said the investment will expand its Juncos, Puerto Rico-based biologics manufacturing facility.
Amgen is investing an additional $300 million to expand its Juncos, Puerto Rico facility.
KEY POINTS
- The expansion is a response to new U.S. tariffs of up to 100% on imported branded drugs.
- Amgen's Juncos site supplies medicines to over 60 countries, strengthening global distribution.
- Including this, Amgen has invested $950 million in Puerto Rico in the past two years.
- Trump's executive order allows tariff exemption if companies produce drugs domestically or accept pricing deals.
COMPANIES
Summarized by Newsio from MarketScreener. How we summarize →